Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.
Mary Caitlin KingVadim GushchinMichelle SittigMary Caitlin KingEkaterina BaronAndrei NikiforchinCarol NierodaArmando SardiPublished in: Annals of surgical oncology (2022)
Selected low- and high-grade appendiceal cancer patients with MCP recurrence able to undergo iterative CRS/HIPEC procedures showed favorable outcomes and such patients should be considered for surgery when feasible. This survival benefit with iCRS/HIPEC is not evidenced in recurrent MCP with signet ring cell morphology.
Keyphrases
- low grade
- high grade
- end stage renal disease
- ejection fraction
- chronic kidney disease
- minimally invasive
- locally advanced
- squamous cell carcinoma
- peritoneal dialysis
- papillary thyroid
- single cell
- type diabetes
- cell therapy
- magnetic resonance imaging
- patient reported outcomes
- radiation therapy
- coronary artery bypass
- squamous cell
- atrial fibrillation
- mesenchymal stem cells
- patient reported
- skeletal muscle
- percutaneous coronary intervention
- surgical site infection